Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Industry: Pharmaceutical

Add a new term

Contributors in Cancer drugs

Become a Contributors

Cancer drugs

3'-deoxy-3'-(18F)fluorothymidine

Pharmaceutical; Cancer drugs

A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope. Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-(18F)fluorothymidin ...

copper Cu 64-ATSM

Pharmaceutical; Cancer drugs

A radioconjugate consisting of a lipophilic copper(II)bis(thiosemicarbazone) labeled with the positron- and beta-emitting isotope (64)Cu with hypoxia-selective and antineoplastic activities. With a ...

fluorine F 18 6-fluorodopamine

Pharmaceutical; Cancer drugs

A radioconjugate consisting of 6-fluorodopamine labeled with fluorine F18 (6-(18F)FDA), with potential diagnostic activity. Upon administration, 6-(18F)FDA is taken up by presynaptic sympathetic ...

technetium Tc 99m demobesin-4

Pharmaceutical; Cancer drugs

A radioconjugate composed of the synthetic bombesin (BB) analog demobesin-4 bound to the radioisotope technetium Tc 99m with receptor ligand and gamma-emitting radioisotope activities. Upon ...

ruthenium Ru 106

Pharmaceutical; Cancer drugs

A radioactive isotope of the rare element ruthenium, a member of the light platinum group. A radioactive plaque containing ruthenium 106 may be inserted into the eye to irradiate ophthalmic tumors.

phosphorus P32

Pharmaceutical; Cancer drugs

A radioactive isotope of phosphorus with beta particle-emitting radiocytotoxic activity. Emitted by phosphorus P32, beta particles directly damage cellular DNA and, by ionizing intracellular water to ...

iodine I 124

Pharmaceutical; Cancer drugs

A radioactive isotope of iodine, a nonmetallic element of the halogen group, with an atomic mass of 124 and a half-life of 4. 18 days with radioisotopic activity. Selectively accumulating in thyroid ...